Summary: Rick Doblin, Ph.D., and Ismail Lourido Ali, J.D., of MAPS speak about the pathway toward FDA-approved medical use of MDMA-assisted therapy for PTSD, non-profit drug development, and transforming drug policy on the WhoWhatWhy podcast with Jeff Schechtman.
WhoWhatWhy Podcast: Are Psychedelics the Cutting Edge Treatment for Mental Illness?
